midazolam has been researched along with n-monodemethyldiltiazem in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dalvie, D; Loi, CM; Smith, DA | 1 |
Gorski, JC; Hall, SD; Jones, DR; Quinney, SK; Zhang, X | 1 |
1 trial(s) available for midazolam and n-monodemethyldiltiazem
Article | Year |
---|---|
Semiphysiologically based pharmacokinetic models for the inhibition of midazolam clearance by diltiazem and its major metabolite.
Topics: Administration, Oral; Adult; Biotransformation; Computer Simulation; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Diltiazem; Drug Interactions; Enzyme Inhibitors; Female; Humans; Infusions, Intravenous; Intestinal Absorption; Intestines; Liver; Male; Midazolam; Models, Biological; Nonlinear Dynamics; Prospective Studies; Reproducibility of Results; Young Adult | 2009 |
1 other study(ies) available for midazolam and n-monodemethyldiltiazem
Article | Year |
---|---|
Which metabolites circulate?
Topics: Humans; Metabolic Clearance Rate; Pharmaceutical Preparations | 2013 |